Stockreport

Intensity Therapeutics Regains Compliance with Nasdaq's Minimum Bid Price Requirement [Yahoo! Finance]

Intensity Therapeutics, Inc.  (INTS) 
PDF biotechnology company focused on the discovery and development of novel intratumoral cancer therapies that are designed to kill tumors and increase immune system recogni [Read more]